April 2 (Reuters) - Emerald Health Therapeutics Inc:
* EMERALD HEALTH THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE C$0.04
* HAD ABOUT $89 MILLION IN CASH AND CASH EQUIVALENTS AS AT MARCH 29, 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.